BioXcel Corporation

BioXcel Corporation

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • AI for Selection of Combination Therapies

    The post AI for Selection of Combination Therapies appeared first on Bioxcel.

  • BioXcel Appoints Dr. Peter Mueller as Chairman of Scientific Advisory Board

    SAB to Guide Advancement of Multiple Therapeutic Programs BRANFORD, Conn., Oct. 12, 2016 (GLOBE NEWSWIRE) — BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced the appointment of Dr. Peter Mueller, Ph.D. as Chairman of its Scientific Advisory Board (“SAB”), which will serve as a strategic resource to the Company as it advances … Continue reading BioXcel Appoin...

  • BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors

    Appointment of industry leader brings broad R&D Experience to Board BRANFORD, Conn., Jan. 05, 2017 (GLOBE NEWSWIRE) — BioXcel, a privately held biopharmaceutical company pioneering the integration of big data analytics and machine learning-based artificial intelligence (AI) with drug development expertise to advance the next wave of medicines, today announced the appointment of Dr. Eric … Continue...

BioXcel Corporation

Category: Content
Type: Blog Article

Generated 6 months ago

New blog articles detected

BioXcel Corporation

Category: Content
Type: Blog Article

Generated 6 months ago

New blog articles detected

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in